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Percutaneous coronary intervention (PCI) is a 
revascularisation intervention for patients with acute 
coronary syndrome. It is a common procedure, 
increasingly used over the past decade. Along with PCI, 
patients are also prescribed a number of medications 
and adherence to the pharmacological therapies is 
vital to improved morbidity and mortality.
Objective
This cross‑sectional study sought to evaluate the long 
term adherence to medications in patients following 
PCI.
Subjects
270 participants who underwent PCI between April 
2003 and March 2004 and who met the inclusion 
criteria were followed up 12‑24 months following the 
PCI.
Methods
Following obtaining informed consent, a self 
administered questionnaire was mailed to participants. 
Information was collected relating to the types of 
medications taken, medication taking behaviours and 
storage of medications.
Results
Overall high rates of self‑reported medication 
adherence were reported. In spite of this, patients 
continued to miss medications or reported stopping 
medications if they felt better or worse. Knowledge 
of storage of medication in particular nitro‑glycerine 
medications was poor.
Conclusions
Findings suggested that following PCI medication 
adherence is high, however knowledge about 
medication storage is limited and patients report 
cessation of medications which they consider to be 
deleterious	or	unnecessary.	These	findings	are	useful	
for informing development of nursing interventions.
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BACKGROUND 
Percutaneous coronary intervention (PCI) is a 
widely used revascularisation strategy for patients 
with acute coronary syndrome (ACS). Over the past 
decade,	refinement	in	the	technology	has	seen	an	
increased use of this method for revascularization 
(Davies 2003). Although PCI is effective in treating 
the	culprit	lesion,	modification	of	the	physiologic	risk	
factors is essential to prevent progress of coronary 
artery disease (Lisspers et al 2005; Yusuf et al 2004; 
Haddock et al 2003; Johansen et al 2001).
Following PCI the majority of the patients receive 
several pharmacological therapies that have been 
demonstrated in randomised controlled trials to be 
effective in the secondary prevention of coronary 
artery disease (Fonarow et al 2001; Rogers et al 
2000; Alexander et al 1998; Krumholz et al 1998; 
Krumholz et al 1997) as well as to prevent restenosis 
of the treated vessel (Spertus et al 2005; Rana et 
al 2005). 
Adherence to medication regimes, described as 
the extent to which patients take medications as 
prescribed (Mihalko et al 2004), is imperative to 
prevent coronary artery disease progression. For 
example, adherence to lipid lowering treatment is 
associated with lower risk of recurrent coronary 
events (Wei et al 2002), while poor compliance with 
hypertension medications is associated with adverse 
health outcomes such as stroke and left ventricular 
hypertrophy (Schroeder et al 2006).
Despite compelling evidence about the effectiveness 
of medications, adherence to treatment has been 
recognised to be a major problem in patients with 
chronic illness (Osterberg et al 2005; Vermeire et 
al 2001) and a large proportion of patients become 
non‑adherent at six months (Osterberg et al 2005; 
Chapman et al 2005). Rates of non‑adherence with 
any long term medication treatment vary from 17% 
to 60%, depending on the characteristics of the 
condition, the treatment, the patient, and the setting 
(Sud	 et	 al	 2005;	 Gottlieb	 2000).	 Of	 significance,	
non‑adherence is the highest when the patients 
are symptom‑free (Gottlieb 2000). This observation 
is	 of	 particular	 significance	 in	 implementation	 of	
secondary prevention interventions.
Long term adherence has been estimated to 
be between 40% (Esposti et al 2004) to 70% 
(Gislason et al 2006; Halpern et al 2006) for 
hypertensive medications and 37‑80% for lipid 
lowering medications (Gislason et al 2006; Kulkarni 
et al 2006; Newby et al 2006; Tsuyuki et al 2001). 
Among elderly patients with ACS adherence to long 
term	lipid	therapy	was	significantly	higher	(40.1%)	
compared to patients with chronic coronary artery 
disease (36.1%) (Jackevicius et al 2002). Adherence 
rates at 1‑2 year follow up for aspirin was 83‑88% 
(Newby et al 2006; Kulkarni et al 2006; Sud et al 
2005), betablockers 61‑78% (Newby et al 2006; 
Kulkarni et al 2006) and 66‑72% for ACE inhibitors 
(Sud et al 2005; Kulkarni et al 2006). 
Lack of adherence to medication results in 
suboptimal control of risk factors leading to risk 
for further cardiovascular events and increased 
hospital admissions (Sokol et al 2005; Aday et al 
2004; Kennedy et al 2002), consequently resulting in 
increased	financial	burden	on	the	health	care	system	
(Vermeire et al 2005; Aday et al 2004). 
Numerous	studies	have	identified	factors	associated	
with poor adherence. These factors include lack of 
knowledge, denial, adverse effects, poor memory 
(Moser et al 1999) and adverse attitudes to treatment 
(Vermeire	 et	 al	 2005).	 Other	 factors	 influencing	
patients’ adherence to medications include patients 
characteristics such as: the cost of medications, the 
number of medications taken by the patient, the 
type of medical intervention and the nature of the 
medical condition (Krueger et al 2005). In addition 
the longer the duration of therapy, the complexity of 
the regimen, and a low perception of need such as 
in	asymptomatic	conditions	influence	adherence	to	
medications. Further the occurrence of side effects 
and low tolerance to effects impact upon adherence 
(Krueger et al 2005; Gregoire et al 2001).
Strategies to improve medication adherence include 
multidisciplinary educational and behavioural 
interventions (World Health Organization 2003) such 
as reminders and reinforcement of the importance 
of medication adherence. Three systematic reviews 
published in the Cochrane library have investigated 
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the effectiveness of various interventions to promote 
adherence to medications. The interventions 
demonstrated to be effective were multifaceted 
and included: education, reminders, counselling, 
self monitoring, reinforcement, simplifying dosing 
regimens, and using adherence aids (Haynes et al 
2000; World Health Organization 2003).
A recent systematic review of the effects of 
interventions for adherence to antihypertensive 
medications reported that reducing the number 
of daily doses, motivational strategies and other 
complex strategies were effective in maintaining 
adherence and improving patient outcomes 
(Schroeder et al 2006; Fahey et al 2005b). 
Interventions used to increase medication adherence 
include: educational interventions, patient 
behavioral interventions, and provider interventions 
(Krousel‑Wood et al 2005; Fahey et al 2005a; Fahey 
et al 2005b; Schedlbauer et al 2004).
Patients who have had PCI generally underestimate 
the severity of their cardiovascular disease and 
have a misconception they are cured due to the 
short hospital stay, rapid procedural technique, and 
immediate potential success of PCI without requiring 
open‑heart surgery (Higgins et al 2001), reducing 
the amount of pain experienced, and facilitating an 
early return to work (Gulanick et al 1998). Given that 
the perception of risk may be lower it is important 
to investigate the mediation adherence behaviour 
in people following PCI.
This study aimed to assess long term medication 
adherence in patients following PCI.
METHODS 
Recruitment 
All patients who underwent elective, primary or 
rescue PCI, between April 1st 2003 and March 31st 
2004 at a major metropolitan teaching hospital in 
NSW	Australia	were	 identified	 from	 the	cardiology	
database and a list was compiled. Attempts were 
made to identify deceased patients. A total of 541 
participants underwent PCI during the study period of 
whom 518 were considered to be potentially eligible 
and who were sent an invitation to participate in 
the study along with a subject information sheet. A 
detailed description of the recruitment method has 
been presented elsewhere (Fernandez et al 2006). 
In brief, participants who had undergone elective, 
primary or rescue PCI, were eligible for the study 
if they were aged between 18‑80 years, had no 
cognitive impairment (telephone mini mental score 
of	more	than	30)	and	had	a	reliable	and	verifiable	
telephone contact number. Participants were 
excluded from the study if they had: a failed PCI 
procedure	requiring	surgical	intervention;	significant	
co‑ morbidities such as cerebrovascular accident with 
significant	 neurological	 deficit;	 malignant	 disease	
and were undergoing active therapy; any condition of 
sufficient	severity	to	impair	co‑operation	in	the	study	
eg chronic alcoholism; a length of hospital stay of 
more than 30 days following the PCI; been transferred 
to a nursing home following the procedure; or unable 
to be contacted. Data were collected from December 
2004 to March 2005. Approval to undertake the 
project was obtained from the facility and university 
ethics	committee.	Numerical	unique	identifiers	and	
password‑protected	 files	 were	 used	 to	 maintain	
patient	privacy	and	confidentiality.
Data collection
A 20 item investigator developed questionnaire 
consisting of items relating to demographic details 
(age, gender, level of education, marital status), 
past medical history, medications currently taken 
and a test battery using validated medication 
adherence questionnaires was administered. 
Participants meeting eligibility criteria were mailed 
a questionnaire, consent form and a reply paid 
envelope. Methods to increase response to postal 
questionnaires, such as telephone reminders were 
used (Edwards et al 2002). In order to obtain a 
representative sample, participants from non‑English 
speaking background were encouraged to complete 
the questionnaire with assistance.
OUTCOMES ASSESSMENT 
Cognitive status 
As impaired cognitive status was an exclusion 
criterion, potential participants completed a 
telephone interview to assess their cognitive status to 
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determine their eligibility for the study. The Telephone 
Interview of Cognitive Status (TICS) which is a 11‑item 
screening test modelled on the Mini Mental State 
Examination (MMSE) questionnaire was adapted 
for this purpose (Brandt et al 1988). The maximum 
score obtainable is 41 points and participants 
with a score of less than 30 are considered to be 
cognitively impaired. The TICS correlates very highly 
(0.94) with the MMSE. Test‑retest reliability of the 
TICS has also been estimated to be high (r 5 0.97) 
(Brandt	et	al	1988).	A	score	of	30	was	identified	as	
the minimum for inclusion in the study, however all 
patients assessed had a TICS score more than 30 
and were eligible for inclusion.
Current medications 
Participants were asked if they were taking 
medications for control of high blood pressure, 
cholesterol, depression, diabetes, body weight, 
breathing	difficulties,	depression	or	pain.	A	chart	audit	
was	undertaken,	to	confirm	participant’s	responses.	
In addition participants were also asked if they were 
receiving medications for quitting smoking and 
preventing blood clots and if they found it bothersome 
to take their medications.
Adherence to medications 
Adherence to medication was assessed by self report 
using the Haynes validated questions (Haynes et 
al 1980) and the Morisky Medication Adherence 
Scale (MAS) (Morisky et al 1986). Pooled data from 
methodologically strong studies demonstrates that 
when compared to pill counts, self reports have a 
sensitivity	of	55%,	specificity	averaging	87%	and	a	
likelihood ratio for a positive test of 4.4 (Stephenson 
et al 1993).
The Haynes Questions 
This	 instrument	 consists	 of	 two	 items.	 The	 first	
item was a previously validated question: “Do you 
regularly	 miss	 taking	 any	 of	 your	 medications”	
(Haynes et al 1980). As the method of questioning 
has been reported to affect the accuracy of 
responses (Stephenson et al 1993) non threatening, 
non judgemental approaches as described in the 
literature were used (Haynes et al 1980). The question 
was therefore prefaced with the following statement: 
“People	often	have	difficulty	taking	their	pills	for	one	
reason	or	another”.	We	are	trying	to	learn	more	about	
that	 experience.	 If	 the	 response	 was	 affirmative,	
participants were asked to report the numbers of 
pills missed in the previous day and week (Haynes 
et al 1980). When compared to pill counts, these 
questions have been reported to have a correlation 
coefficient	of	0.74	(p<0.0001),	sensitivity	of	96%,	
specificity	50%	and	a	positive	predictive	value	of	70	
% (Haynes et al 1980).
Morisky Medication Adherence Scale (MAS)
The Morisky Medication Adherence Scale (MAS) 
(Morisky et al 1986) comprises of three questions 
which include: 
• Do you ever forget to take your medicine?
• When you feel better do you sometimes stop 
taking your medicine?
• Sometimes if you feel worse when you take the 
medicine do you stop taking it?
Reliability of these items (item to total correlation 
coefficients	of	0.48	to	0.56)	and	the	total	scale	has	
been reported and is modest (alpha=0.64) (Morisky 
et al 1986).
Storage of medications was assessed using 
questions adapted from Gray’s recommended items 
(Gray 1990). Medication management systems, 
such as any unit dose system (Dosett® systems, 
blister packs), were referred to as compliance aids 
in the Medication Management Ability section of 
the questionnaire. Patients were asked particularly 
about the storage of sublingual nitro‑glycerine 
medications.
Statistical analysis
All analyses were undertaken using SPSS Version 13. 
Categorical data have been presented as percentages 
and continuous data are presented as means (SD). 
Differences between continuous variables were 
assessed using t‑tests and the Chi‑square test was 
used for categorical variables. Comparisons were 
considered	to	significant	at	p<0.05.
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RESULTS 
Questionnaires were sent to 270 participants of which 
202 (males n=148, females n= 54) were returned 
demonstrating a response rate of 75%. The age of the 
participants ranged from 35‑87 years with a mean 
age of 64 years (SD 11.7). Overall female participants 
were	significantly	older	than	males	(p<0.0001).	More	
than half the patients (60%) were retired and nearly 
three quarters of the participants were married or 















Use of Medications 
All except three patients reported taking medications, 
most commonly to control high cholesterol, high 
blood pressure and to prevent blood clots. 
Approximately 50% of the patients were taking 
3‑4 types of medications each day. The use of 
nitro‑glycerine medications for the relief of angina 
was minimal, with the majority (84%) reporting not 
taking the medication in  the previous four weeks. The 
remaining patients indicated they used nitro‑glycerine 
medications less than once a week (9%), 1‑2 times 
each week (3.7%), 3 or more times each week (2.7%) 
and 1‑3 times each day (0.5%). 
Medication adherence 
A large proportion of the participants (94.6%) 
reported they did not regularly miss taking their 
medications, however approximately 11% indicated 
they had missed some of their medications in the 
previous week. Of those participants who reported 
they missed taking some of their medication four had 
missed more than three tablets. A small proportion 
of the participants reported they intentionally missed 
tablets if they felt better, worse or were going out.
Figure 1: Medications taken by participants
Table 2: Medication adherence rates of participants
Frequency (%)
Regularly miss taking 
medications 7/198 (3.5%)*
Missed tablets in the last week 22/198 (10.9)*
Number of tablets usually missed in a week 
None 183/202 (90.6%)
1‑3 tablets 15/202 (7.5%)
4 or more 4/202 (2%)
Could not remember 8/202 (4%)
Stops taking medications if 
feeling better 4/196 (2%)*
Stops taking medications if 
feeling worse 9/195 (4.5%)*
Stops taking medications if 
going out 10/197 (5%)*
*Missing data
Medication Storage
One hundred and sixty eight participants (83%) 
indicated they stored their medications in their 
original containers and a third used some form of 
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prescribed any medications for relief of chest pain. 
The majority of the patients (84%) did not have any 
chest pain in the four weeks prior to the survey and 
therefore did not require any nitro‑glycerine tablets 
or sprays.
Less than three quarters (68.1%) of the participants 
reported the correct method for storage of 
nitroglycerine medications and 25% indicated they 
were not aware of the correct method for storage. 
The remaining 6% stated these medications could 
be stored in tissues, refrigerator or along with other 
medications.
DISCUSSION 
There is overwhelming clinical evidence that supports 
the use of medications for patients following 
acute coronary syndrome to prevent morbidity 
and mortality. Therefore adherence to medication 
recommendations is crucial for the reduction of risk 
factors and the prevention of the progress of coronary 
artery disease. The evidence also indicates that a 
substantial proportion of people have diminished 
adherence to long term therapy. Pharmacological 
management is most likely to be effective when 
people adhere to their prescribed medication regimes 
on an ongoing basis. Non‑adherence has important 
economic implications, because patients who fail to 
adhere to medication regimens cannot realise the 
cardio	protective	benefits	that	are	associated	with	
continuous treatment.
A large proportion of the participants reported taking 
medications for lowering cholesterol, blood pressure 
and prevention of blood clots which is consistent with 
the general literature (Newby et al 2006; Kulkarni 
et al 2006). However due to the method of data 
collection	it	is	difficult	to	differentiate	between	patient	
non‑adherence and physician non‑prescription for 
the remaining patients.
In spite of the lower perception of risk attributed 
to people undergoing PCI, very few patients in this 
study reported they missed taking their medications. 
However the study highlights the fact that a limited 
number of participants reported the correct method 
for the storage of nitro‑glycerine medications, which is 
35% kept all their medications in one container. 
Of those who used compliance aids, more than 
half (59.6%) indicated they used an approved 
compliance aid which included Webster packs, 
weekly dossette boxes, and daily pill boxes to organise 
their medications. The remaining used plastic cups, 
containers or bags, checklists, palm cards, aluminium 
foil and boxes to organise their medications. Some 
participants indicated they relied on their partner to 
organise the medications. 
A	 fifth	 of	 the	 participants	 reported	 using	 special	
systems to remind them to take their medications. 
These methods included use of an approved system, 
reminder by spouse, keeping the medications in 
a prominent location in the house and according 
to the meal or sleep schedule. Approximately half 
the patients stated it was not bothersome to take 
medications. Participants had excellent knowledge of 
recommended actions when they felt side effects of 
medications, with the majority (87.8%) reporting they 
would notify their doctor before making any changes 
to their medications. The remaining participants 
indicated they would stop taking their medications 
until the next time they visited their doctor (10.2%) 
or did not know what to do (2%). 
Table 3: Storage of medications
Frequency (%)
Keeps medications in original 
containers 168/199 (83.2%)
Keeps medications in one 
container 75/192 (35.1%)
Currently using a compliance 
aid to organise medications 60/195 (29.7%)
Using an approved 
compliance system 34/57 (16.8%)
Currently using a system as a 
reminder to take medications 41/200 (20.3%)
Using an approved reminder 
system (n=44) 15/44 (34.1%)
Specific questions were asked relating to the 
incidence of chest pain, the use and storage of 
medications for the relief of chest pain. Nearly a third 
(29%) of the participants indicated they were not 
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of concern as improper storage of these medications 
can render them ineffective leading to increased 
morbidity and hospitalisations. 
Implications for nursing practice
In light of the importance of medication adherence 
in modulating patient outcomes, nurses need to 
recommend strategies to integrate medication 
adherence.	 The	 findings	 from	 this	 study	 confirm	
that patients need the knowledge, attitude, and 
skills to follow an appropriately prescribed regimen. 
In addition, patients also require knowledge for 
the proper storage of medication which is vital 
as improper storage can render the medication 
ineffective and thus all attempts made to enhance 
adherence are futile. Multidisciplinary efforts to 
enhance adherence to medication may improve 
adherence to medications. Many patients are 
unaware of the importance of adhering to the 
medication	regime	which	is	reflected	in	their	reports	
of not taking medication when they feel better, their 
condition worsened, or if they were going out. Another 
reason for non‑adherence could be the fact that the 
majority of these patients had multiple co‑morbidities 
and the evidence supports poor adherence among 
persons with three or more co‑morbid conditions. This 
finding	is	important	for	nursing	practice	as	nurses	
can play an important role in raising their awareness 
of non‑adherent behaviours.
Once	 adherence	 problems	 have	 been	 identified,	
effective communication between patients and 
nurses or other health care providers is essential 
and forms the basis for actions and strategies. In 
addition,	nurses	can	provide	detailed	and	specific	
information in a manner that is easy to understand to 
increase knowledge and thereby increase adherence 
to medications. Nurses can also assist patients to 
identify mechanisms that promote adherence to a 
prescribed regimen.
Providing patients with skills such as problem solving, 
self‑monitoring, and developing self‑prompting 
and reminder systems, can also empower patients 
and increase adherence. Nurses are in a unique 
position to educate patients about the importance 
of medication adherence in reducing overall health 
care costs and improving health outcomes. Thus, a 
multidisciplinary approach led by nurses could be an 
effective strategy to improve medication adherence 
rates in patients with chronic disease.
Strengths and Limitations
The major strength of this cross‑sectional study was 
the	high	response	rate	obtained	from	a	well	defined	
cohort, free of cognitive impairment, as judged by TICS 
criteria. In addition, this study provides data relating to 
medication adherent behaviours of patients following 
PCI in a usual care setting.
A limitation of the self report method used to measure 
adherence in this study is that it can overestimate 
adherence when compared to chemical markers and 
electronic monitoring of pill use, and its accuracy 
depends on the patient’s cognitive abilities and the 
honesty of replies (Fisher 1993). Currently various 
methods are used to measure medication adherence 
and until a gold standard that is cost effective is 
available, measurement of medication adherence 
will continue to have limitations. The high adherence 
rates could be due to a Hawthorne effect. Another 
limitation was that adherence to blood pressure 
or cholesterol lowering medications could not 
be compared against actual blood pressure and 
cholesterol values to assist with examining the effect 
of adherence and blood pressure or cholesterol 
control. The findings should be considered in 
light of the fact that this study was undertaken in 
patients who had PCI at a single centre and the 
socio demographic patterns of the participants could 
influence	their	adherence	to	medications.	In	addition,	
despite extensive efforts to increase response rates, 
patients who were non‑adherent to medications 
would be less likely to respond to questionnaires 
resulting	in	a	significant	participant	bias.
Further studies need to be undertaken to accurately 
measure	adherence	and	the	factors	that	influence	
adherence in this group of patients. To improve the 
medication taking behaviour in this cohort of patients 
it is vital to explore the characteristics of patients who 
do not adhere to long term treatment; the results can 
then be used to develop new strategies to improve 
medication adherence in this cohort. In addition 
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studies linking medication compliance with improved 
patient risk factors need to be undertaken.
In spite of these limitations, through the exploration 
of medication adherence behaviours, interventions to 




Adherence to medications remains imperative 
to prevent the progress of coronary artery 
disease and restenosis of the revascularised 
artery. Multidisciplinary efforts with increased 
patient‑centeredness, emphasis on the patient’s 
perspective and shared‑decision‑making might lead 
to improved adherence to medications.
Summary of key points 
Non‑adherence to medications can result in 
progress of coronary artery disease, further need 
for revascularisation and poor outcomes.
The majority of the participants were receiving 
pharmacological therapy according to guidelines.
Adherence to medications in these participants was 
similar to those with chronic illness.
Participants had a decreased knowledge of the 
storage of nitro‑glycerine medications.
Strategies to enhance medication adherence need 
to be incorporated into patient care. 
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